{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:58:40Z","timestamp":1790683120493,"version":"4.1.0"},"reference-count":18,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2020,9,15]]},"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1136\/ejhpharm-2020-002440","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:25:27Z","timestamp":1601054727000},"page":"284-286","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["External contamination of antineoplastic drug vials: an occupational risk to consider"],"prefix":"10.1136","volume":"29","author":[{"given":"Camille","family":"Cotteret","sequence":"first","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe-Henri","family":"Secretan","sequence":"additional","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Gilles-Afchain","sequence":"additional","affiliation":[{"name":"Pharmacy, Centre R\u00e9gional de Lutte Contre le Cancer Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Rousseau","sequence":"additional","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Vidal","sequence":"additional","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Salguero-Hernandez","sequence":"additional","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Batista","sequence":"additional","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Valverde","sequence":"additional","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Guitton","sequence":"additional","affiliation":[{"name":"Pharmacy, Centre R\u00e9gional de Lutte Contre le Cancer Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cisternino","sequence":"additional","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"},{"name":"Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, Inserm UMR-S1144, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-8843","authenticated-orcid":false,"given":"Jo\u00ebl","family":"Schlatter","sequence":"additional","affiliation":[{"name":"Pharmacie clinique, H\u00f4pital universitaire Necker\u2013Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"2025090701101901000_29.5.284.1","unstructured":"National Institute for Occupational Safety and Health . NIOSH alert. Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings, 2004. Available: https:\/\/www.cdc.gov\/niosh\/docs\/2004-165\/pdfs\/2004-165.pdf?id="},{"key":"2025090701101901000_29.5.284.2","unstructured":"United States Pharmacopeia (USP) . USP General Chapter <800> Hazardous Drugs \u2013 Handling in Healthcare Settings, 2017. Available: http:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/our-work\/healthcare-quality-safety\/general-chapter-800.pdf"},{"key":"2025090701101901000_29.5.284.3","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp180564"},{"key":"2025090701101901000_29.5.284.4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(79)91939-1","article-title":"Mutagenicity in urine of nurses handling cytostatic drugs","volume":"1","author":"Falck","year":"1979","journal-title":"Lancet"},{"key":"2025090701101901000_29.5.284.5","doi-asserted-by":"crossref","DOI":"10.1007\/s10661-016-5762-9","article-title":"Environmental monitoring by surface sampling for cytotoxics: a review","volume":"189","author":"Marie","year":"2017","journal-title":"Environ Monit Assess"},{"key":"2025090701101901000_29.5.284.6","first-page":"165","article-title":"Important exposure controls for protection against antineoplastic agents: highlights for oncology health care workers","volume":"59","author":"Alehashem","year":"2018","journal-title":"Work"},{"key":"2025090701101901000_29.5.284.7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2478\/aiht-2018-69-3137","article-title":"Occupational exposure to cytotoxic drugs: the importance of surface cleaning to prevent or minimise exposure","volume":"69","author":"Viegas","year":"2018","journal-title":"Arh Hig Rada Toksikol"},{"key":"2025090701101901000_29.5.284.8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2478\/aiht-2018-69-3125","article-title":"A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments","volume":"69","author":"Dugheri","year":"2018","journal-title":"Arh Hig Rada Toksikol"},{"key":"2025090701101901000_29.5.284.9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ajhp\/62.5.475","article-title":"Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies","volume":"62","author":"Connor","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"2025090701101901000_29.5.284.10","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/men050"},{"key":"2025090701101901000_29.5.284.11","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080621"},{"key":"2025090701101901000_29.5.284.12","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1248\/bpb.b12-00628","article-title":"Comparison of contamination levels on the exterior surfaces of vials containing platinum anticancer drugs in Japan","volume":"35","author":"Naito","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"2025090701101901000_29.5.284.13","first-page":"451","article-title":"Verification of external surface contamination of Japanese 5-fluorouracil vials and removal of contamination by washing the vials","volume":"39","author":"Hama","year":"2013","journal-title":"Iryo Yakugaku"},{"key":"2025090701101901000_29.5.284.14","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4904-355"},{"key":"2025090701101901000_29.5.284.15","doi-asserted-by":"publisher","DOI":"10.1177\/1078155213482683"},{"key":"2025090701101901000_29.5.284.16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00420-014-0993-y","article-title":"Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach","volume":"88","author":"Moretti","year":"2015","journal-title":"Int Arch Occup Environ Health"},{"key":"2025090701101901000_29.5.284.17","unstructured":"Food and Drug Administration . Center for Drug Evaluation and Research (CDER). Analytical procedures and methods validation for drugs and biologics, 2015. Available: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm"},{"key":"2025090701101901000_29.5.284.18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1078155219868525","article-title":"External contamination of antineoplastic drug containers from a Canadian wholesaler","volume":"26","author":"Hilliquin","year":"2020","journal-title":"J Oncol Pharm Pract"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2020-002440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T08:10:27Z","timestamp":1757232627000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2020-002440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,8,23]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/ejhpharm-2020-002440"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2020-002440","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]}}}